0001209191-20-059157.txt : 20201118 0001209191-20-059157.hdr.sgml : 20201118 20201118170008 ACCESSION NUMBER: 0001209191-20-059157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bondurant William CENTRAL INDEX KEY: 0001792295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36330 FILM NUMBER: 201325776 MAIL ADDRESS: STREET 1: C/O CASTLIGHT HEALTH, INC. STREET 2: 150 SPEAR STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLIGHT HEALTH, INC. CENTRAL INDEX KEY: 0001433714 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 261989091 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-671-4683 MAIL ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: VENTANA HEALTH SERVICES, INC. DATE OF NAME CHANGE: 20090831 FORMER COMPANY: FORMER CONFORMED NAME: MARIA HEALTH INC DATE OF NAME CHANGE: 20080429 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001433714 CASTLIGHT HEALTH, INC. CSLT 0001792295 Bondurant William C/O CASTLIGHT HEALTH, INC. 150 SPEAR STREET, SUITE 400 SAN FRANCISCO CA 94105 0 1 0 0 Chief Financial Officer Class B Common Stock 2020-11-16 4 M 0 1875 0.00 A 129784 D Class B Common Stock 2020-11-16 4 M 0 3750 0.00 A 133534 D Class B Common Stock 2020-11-16 4 M 0 3750 0.00 A 137284 D Class B Common Stock 2020-11-16 4 M 0 9375 0.00 A 146659 D Class B Common Stock 2020-11-16 4 M 0 8437 0.00 A 155096 D Class B Common Stock 2020-11-16 4 M 0 52817 0.00 A 207913 D Class B Common Stock 2020-11-16 4 M 0 56250 0.00 A 264163 D Class B Common Stock 2020-11-17 4 S 0 48844 1.1391 D 215319 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 1875 0.00 D Class B Common Stock 1875 1250 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 3750 0.00 D Class B Common Stock 3750 3750 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 3750 0.00 D Class B Common Stock 3750 8750 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 9375 0.00 D Class B Common Stock 9375 21875 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 8437 0.00 D Class B Common Stock 8437 25313 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 52817 0.00 D Class B Common Stock 52817 211269 D Restricted Stock Units (RSU) 2020-11-16 4 M 0 56250 0.00 D Class B Common Stock 56250 243750 D On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Includes 1,770 shares of Class B Common Stock acquired under the Issuer's employee stock purchase plan on August 31, 2020. Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. Represents the weighted average sales price per share. The shares sold at prices ranging from $1.13 to $1.17 shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. 1/4th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. 1/4th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. 1/16th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. 1/16th of the RSUs vested on February 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. 1/16th of the RSUs vest on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. /s/ Mary Ahern, by power of attorney 2020-11-18 EX-24.4_945841 2 poa.txt POA DOCUMENT POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Alex Shvartsman and Mary Ahern as his true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a representative of Castlight Health, Inc. (the "Company"), any and all Form ID, or Form 3, 4 or 5 reports and any amendments thereto required to be filed by the undersigned in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and the rules thereunder with respect to transactions in the Company's securities; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, or Form 3, 4 or 5 report and any amendments thereto and timely file such report with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney in-fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney in-fact may approve in his or her discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or her/his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that no such attorney in-fact, in serving in such capacity at the request of the undersigned, is hereby assuming, nor is the Company hereby assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Form 3, 4 or 5 reports with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of November 16, 2020. /s/ Will Bondurant Will Bondurant